1.Academician Li Lianda talking about doctors doing scientific research.
China Journal of Chinese Materia Medica 2015;40(17):3352-3354
At present, Chinese medical field faces with an important problem of how to correctly handle the relationship between medical and scientific research. Academician Li Lianda advocates doctors doing scientific research under the premise of putting the medical work first. He points out that there are many problems in the process of doctors doing scientific research at present such as paying more attention to scientific research than medical care, excessively promoting building scientific research hospital, only paying attention to training scientific talents, research direction be flashy without substance, the medical evaluation system should be improved and so on. Medical, scientific research and teaching are inseparable because improving medical standards depends on scientific research and personnel training. But not all doctors need to take into account of medical treatment, scientific research and teaching in the same degree while not all hospitals need to turn into three-in-one hospital, scientific research hospital or teaching hospital. It must be treated differently according to the actual situation.
Altitude
;
Biomedical Research
;
education
;
manpower
;
trends
;
Humans
;
Physicians
;
psychology
;
statistics & numerical data
2.Specificity of traditional Chinese medicine's clinical re-evaluation.
Lian-Da LI ; Yi-Kui LI ; Feng-Jie LI
China Journal of Chinese Materia Medica 2014;39(1):3-4
Clinical re-evaluation is to verify the drug's safety and effectiveness again,while the drug itself has not been improved. However, due to the complexity of traditional Chinese medicine, ingredients in bulk drugs, prescription, productive processes, quality standards and other aspects need to be enhanced. So improving the quality, safety and effectiveness of traditional Chinese medicine by clinical re-evaluation is also very necessary. Therefore, except for achieving those basic requirements of medicine, it should also be improved on itself and pay full attention to the particularity, then traditional Chinese medicine's clinical re-evaluation will play its due role.
Drug Prescriptions
;
standards
;
Drugs, Chinese Herbal
;
standards
;
therapeutic use
;
Humans
;
Medicine, Chinese Traditional
;
standards
;
Quality Control
;
Safety
;
standards
3.The effect of ankle strategy stability limit training on balance and gait in recovering stroke patients
Kui LI ; Yi FU ; Xin LI ; Dongfeng XIE ; Weihong QIU
Chinese Journal of Physical Medicine and Rehabilitation 2012;34(2):113-115
Objective To explore the effect of ankle strategy stability limit training on balance and gait in recovering stroke patients with hemiplegia. Methods Forty recovering stroke patients were randomized into an intervention group and a control group.The patients in the intervention group were given ankle strategy stability limit training using visual feedback on the static long sets of a Smart Equitest Balance Master (SEBM) machine.Those in the control group practiced routine postural balance training using mirror visual feedback in parallel bars.Both groups of patients practiced balance and posture control for 30 minutes,once daily,6 days a week for two weeks. Both groups were also given routine therapy and other rehabilitation.The patients' balance function was evaluated using the Berg Balance Scale (BBS),and their gait was assessed using the walk across technique (WA). Results There was no significant difference between the two groups with regard to general information,BBS scores or WA results before treatment.After 2 weeks of treatment,BBS scores as well as the step length and pace in the WA improved significantly in both groups,but all improved significantly more in the intervention group.There was no significant difference in width of gait. Conclusion Ankle strategy stability limit training can enhance weight-bearing on stroke patients' affected foot as well as their balance and the symmetry of their steps.
5.Unrelated umbilical cord blood stem cell transplantation in a patient with chronic myelocytic leukemia.
Yu-deng LIN ; Yi-kui SHEN ; Yong-kang LI
Chinese Journal of Pediatrics 2006;44(8):586-586
Blood Donors
;
Child
;
Cord Blood Stem Cell Transplantation
;
adverse effects
;
methods
;
Female
;
Follow-Up Studies
;
Graft vs Host Disease
;
prevention & control
;
Humans
;
Infant, Newborn
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
surgery
;
Transplantation, Homologous
;
Treatment Outcome
6.Controlled release by novel lysostaphin-loaded hydroxyapatite/chitosan composites.
Jin-Cheng WANG ; Bai XUE ; Kui-Kui GE ; Yi-Han WANG ; Guo-Dong LI ; Qing-Shan HUANG
Acta Pharmaceutica Sinica 2014;49(9):1331-1339
Lysostaphin is highly effective on eliminating methicillin resistant Staphylococcus aureus (MRSA). In order to achieve controlled release of lysostaphin, a biocompatible drug carrier is needed. Hydroxyapatite/chitosan (HA/CS) composites were chosen to carry lysostaphin and sample composites with different weight ratios of HA to CS, including 80/20, 70/30, 60/40, and 40/60, were prepared. Multiple analyses were performed to determine the structural and physicochemical properties of the composites, including scanning electron microscopy, X-ray diffraction and Fourier transform infrared spectroscopy. We immersed HA/CS composites loaded with 1 wt% lysostaphin to test in vitro release activity and cultured MC3T3-E1 cells to carry out biocompatibility test. The result of the release behavior of the composites revealed that the controlled release of lysostaphin from 60/40 HA/CS composites was the highest release rate of (87.4 ± 2.8)%, which lasted for 120 hours. In biocompatibility testing, MC3T3-E1 cells were able to proliferate on the surface of these composites, and the extract liquid from the composites could increase the growth of the cells. These results demonstrate the controlled release of lysostaphin from HA/CS composites and their biocompatibility, suggesting the potential application of these composites to bone injury and infection applications.
3T3 Cells
;
Animals
;
Biocompatible Materials
;
Chitosan
;
chemistry
;
Delayed-Action Preparations
;
Drug Carriers
;
chemistry
;
Durapatite
;
chemistry
;
Lysostaphin
;
pharmacology
;
Materials Testing
;
Methicillin-Resistant Staphylococcus aureus
;
Mice
;
Microscopy, Electron, Scanning
;
X-Ray Diffraction
7.Releasing aqueous humor of anterior chamber to treat early elevated lOP after lCL implantation
Lu, XIONG ; Kui-Xian, YI ; Yi-Peng, DENG ; Xiao-Li, PENG
International Eye Science 2015;(2):367-369
To explore the effect of releasing aqueous humor of anterior chamber through lateral incision of cornea in treating early elevated intraocular pressure ( lOP ) after implantation of implantable collamer lens ( lCL) .METHODS: Patients with elevated lOP were analyzed after lCL implantation. When the lOP>25mmHg, aqueous humor was released slowly through lateral incision of cornea, and made the lOP reduce to 10 ~13mmHg. After operation, lOP was measured every 2h. The releasing of aqueous humor was repeated until the lOP was decreased to normal.RESULTS: One hundred sixty - seven patients ( 330 eyes) were implanted lCL, while the lOP of 32 patients (62 eyes) was higher than 25mmHg after lCL implantation. Viscoelastic material was found in aqueous humor of most of high lOP patients, and the lOP of 48 eyes did not increase again through releasing aqueous humor once. The lOP of all these eyes was decreased to normal through releasing aqueous humor in 3 times at most. There were no abnormal in postoperative follow-up.CONCLUSlON:The main reason of early elevated lOP after lCL implantation is the remaining of viscoelastic material of eyes. Releasing aqueous humor through lateral incision of cornea can decrease lOP effectively. lt is a simple, safe, painless and repetition, which the patients are willing to accept.
8.Urgency and necessity of standardisation of chinese medicine with confusions of compound Danshen preparations.
China Journal of Chinese Materia Medica 2008;33(4):349-352
Through analysing the complicated phenomenon of the traditional Chinese medicine product, we propose the standardization for the traditional Chinese medicine. Taking compound Danshen preparation for example, the status of our standardization of the traditional Chinese medicine is connected with the chaos of the raw material, vehicle, production process, quality criteria and clinical application. So we propose the countermeatures to strengthen the construction of standardization for the traditional Chinese medicine.
Drugs, Chinese Herbal
;
Medicine, Chinese Traditional
;
standards
;
Salvia miltiorrhiza
10.Effect and mechanism of methyl protodioscin in protecting cardiomyocytes against anoxia/reoxygenation injury.
Zong NING ; Yi-kui LI ; Yan ZHOU
Chinese Journal of Integrated Traditional and Western Medicine 2010;30(4):407-409
OBJECTIVETo study the effect and mechanism of methyl protodioscin (MPD), an active ingredients of yamogenin, in protecting cardiomyocytes (CMC) against anoxia/reoxygenation (A/R) injury.
METHODSCultured CMCs of neonatal SD rats were randomly divided into three groups, cells in Group A were untreated normal cells, cells in Group B and C were made to injury CMC model by A/R, and only those in Group C were treated with MPD. Levels of ATPase activity and lactate dehydrogenase (LDH) in cell membrane of CMCs were determined. Besides, the mRNA expression of sodium-calcium exchanger (NCX) in MPD treated CMCs was detected.
RESULTSAs compared with Group B, the degree of CMC injury was significantly milder and the activities of Na+ -K+ -ATPase and Ca2+ -Mg2+ -ATPase were higher in Group C after cells were treated with MPD in concentration of 10 microg/mL and 50 microg/mL. The mRNA expression of NCX in CMCs was down-regulated after MPD treatment (P < 0.05).
CONCLUSIONMPD could maintain the low calcium internal environment in CMCs by way of protecting the membranous function of Na+ -pump and Ca2+ -pump, and influencing the Ca2+ transmembrane transportation in CMCs.
Animals ; Cell Hypoxia ; Cells, Cultured ; Diosgenin ; analogs & derivatives ; pharmacology ; Myocardial Reperfusion Injury ; metabolism ; Myocytes, Cardiac ; drug effects ; metabolism ; Oxygen ; adverse effects ; Rats ; Rats, Sprague-Dawley ; Saponins ; pharmacology